🇺🇸 FDA
Patent

US 10663473

Method of identifying a status of a mucosal intestinal epithelial barrier to improve treatment of inflammatory bowel disease

granted A61KA61K2039/505A61K2039/55

Quick answer

US patent 10663473 (Method of identifying a status of a mucosal intestinal epithelial barrier to improve treatment of inflammatory bowel disease) held by Maximus Diagnostic Technologies LLC expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Maximus Diagnostic Technologies LLC
Grant date
Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/505, A61K2039/55, A61K31/4035, A61K31/4245